These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7077230)

  • 1. Interlaboratory comparison of radioimmunological calcitonin determination.
    Raue F
    J Clin Chem Clin Biochem; 1982 Mar; 20(3):157-61. PubMed ID: 7077230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
    Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
    Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
    Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
    J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the calcitonin radioimmunoassay.
    Wood WG; Müller OA; Stalla G; Scriba PC
    J Clin Chem Clin Biochem; 1979 Dec; 17(12):781-7. PubMed ID: 547038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDN-21: possible tumor marker for medullary thyroid carcinoma.
    Takami H; Shikata J; Horie H; Sekine K; Ito K
    J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlaboratory comparison of radioimmunological parathyroid hormone determination.
    Eur J Clin Invest; 1978 Jun; 8(3):149-54. PubMed ID: 99312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of new assays for determination of serum calcitonin concentrations.
    Weissel M; Kainz H; Tyl E; Ogunyemi E; Woloszczuk W
    Acta Endocrinol (Copenh); 1991 May; 124(5):540-4. PubMed ID: 2028712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum calcitonin radioimmunological determination in the diagnosis of medullary thyroid carcinoma (author's transl)].
    Delorme ML; Merceron R; Raymond JP; Klotz HP
    Ann Endocrinol (Paris); 1974; 35(3):289-90. PubMed ID: 4463798
    [No Abstract]   [Full Text] [Related]  

  • 14. [The determination of calcitonin for hospital use (author's transl)].
    Raue F; Minne H; Schäfer D; Ziegler R
    MMW Munch Med Wochenschr; 1977 Feb; 119(7):219-24. PubMed ID: 403447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The setting up of human serum calcitonin radioimmunoassay and its clinical application].
    Zhan Z; Meng X; Chen L; Zhou X; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):236-40. PubMed ID: 10453498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma.
    Tashjian AH; Wolfe HJ; Voelkel EF
    Am J Med; 1974 Jun; 56(6):840-9. PubMed ID: 4598527
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunoassay for calcitonin in medullary thyroid carcinoma.
    Deftos LJ
    JAMA; 1974 Jan; 227(4):403-6. PubMed ID: 4859674
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.
    Samaan NA; Hill CS; Beceiro JR; Schultz PN
    J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426
    [No Abstract]   [Full Text] [Related]  

  • 20. [The determination of human calcitonin by an radioimmunological method].
    Moukhtar MS
    Biomed Pharmacother; 1984; 38(5):257-60. PubMed ID: 6525422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.